FDA NDC
Abilify Asimtufii
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 59148-102
- Proprietary name
- Abilify Asimtufii
- Nonproprietary name
- Aripiprazole
- Labeler
- Otsuka America Pharmaceutical, Inc
- Dosage form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Strength
- 720 mg/2.4mL
Run it in Rivvi
Which 2027 plans near you dropped or restricted Aripiprazole?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.